Article
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy
16 Jan 2017
Abstract excerpt
Androgen receptor (AR) signaling remains the major oncogenic pathway in prostate cancer (PCa). Androgen-deprivation therapy (ADT) is the principle treatment for locally advanced and metastatic disease. However, a significant number of patients acquire treatment resistance leading to castration resistant prostate cancer (CRPC). Epigenetics, the study of heritable and reversible changes in gene expression without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
